Inventor
GOPAL SRIHARI
US15 patents
⚠️ This page may combine multiple inventors who share the name “GOPAL SRIHARI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
9 patentsUS10143693B2Dec 4, 2018
Dosing regimen for missed doses for long-acting injectable paliperidone esters
JANSSEN PHARMACEUTICALS INC31 citations85
US11998525B2Jun 4, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC5 citations83
US11266627B1Mar 8, 2022
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC12 citations83
US12161622B2Dec 10, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12150929B2Nov 26, 2024
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC2 citations71
US12419859B2Sep 23, 2025
Compositions and methods for the treatment of depression
JANSSEN PHARMACEUTICALS INC0 citations60
US12171743B2Dec 24, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US11998524B2Jun 4, 2024
Forms of aticaprant
JANSSEN PHARMACEUTICALS INC0 citations60
US12201610B2Jan 21, 2025
Compositions comprising aticaprant
JANSSEN PHARMACEUTICALS INC0 citations53
JANSSEN PHARMACEUTICA NV
6 patentsUS11324751B1May 10, 2022
Dosing regimens associated with extended release paliperidone injectable formulations
JANSSEN PHARMACEUTICA NV3 citations67
US11304951B1Apr 19, 2022
Dosing regimens associated with extended release paliperidone injectable formulations
JANSSEN PHARMACEUTICA NV4 citations67
US11666697B2Jun 6, 2023
Methods for ensuring resuspension of paliperidone palmitate formulations
JANSSEN PHARMACEUTICA NV3 citations61
US11723569B2Aug 15, 2023
Methods of identifying schizophrenia patients at risk for relapse
JANSSEN PHARMACEUTICA NV0 citations59
US12208100B2Jan 28, 2025
Dosing regimens associated with extended release paliperidone injectable formulations
JANSSEN PHARMACEUTICA NV0 citations56
US12472184B2Nov 18, 2025
Dosing regimens associated with extended release paliperidone injectable formulations
JANSSEN PHARMACEUTICA NV0 citations45